Letter

Antihistamines for anaphylaxis?

Primary outcome measures

BMJ 2009; 339 doi: 10.1136/bmj.b3368 (Published 18 August 2009)
Cite this as: BMJ 2009;339:b3368

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Simon G A Brown, professor, emergency medicine1
  1. 1Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia
  1. simon.brown{at}uwa.edu.au

    Andreae and Andreae recommend that future trials of antihistamines in anaphylaxis should use a primary outcome of “whether antihistamines result in reduced mortality.”1

    Given that death …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular